ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Beta-(1,3/1,6)-D-glucan Helps to Decrease Opportunistic Infections in Crohn's Disease Patients Treated with Biological Therapy

Journal: Archives of Clinical Gastroenterology (Vol.1, No. 1)

Publication Date:

Authors : ; ;

Page : 005-008

Keywords : Crohn's disease; Beta-glucan; Clinical trial; Maintenance therapy;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Background: Secondary intercurrent infections in patients with inflammatory bowel disease (IBD) represent a very important problem in daily clinical practice because of their significant contribution to quality of life and work ability. Beta-glucans are known to act as non-specific immunomodulators that exhibit an anti-inflammatory effect as evident in animal and human studies. Imunoglukan P4H® capsules are nutritional supplement containing 100 mg of beta-(1,3/1,6)-D-glucan pleuran isolated from oyster mushroom Pleurotus ostreatus and 100 mg of vitamin C.

Last modified: 2018-09-04 14:03:30